RespireRx Pharmaceuticals Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
RespireRx Pharmaceuticals Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 2B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 2B 0 0% Sep 30, 2023 10-Q 2023-11-17
Q2 2023 2B 0 0% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 2B 0 0% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 2B 0 0% Dec 31, 2022 10-Q 2023-11-17
Q3 2022 2B 0 0% Sep 30, 2022 10-Q 2022-11-17
Q2 2022 2B 0 0% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 2B 0 0% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 2B 0 0% Dec 31, 2021 10-K 2023-04-17
Q3 2021 2B +1B +100% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 2B +1B +100% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 2B +1.94B +2977% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 2B 0 0% Dec 31, 2020 10-K 2022-04-15
Q3 2020 1B +935M +1438% Sep 30, 2020 10-Q 2020-11-23
Q2 2020 1B +935M +1438% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 65M 0 0% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 2B +1.94B +2977% Dec 31, 2019 10-K 2021-04-15
Q3 2019 65M 0 0% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 65M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 65M 0 0% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 65M 0 0% Dec 31, 2018 10-K 2020-04-14
Q3 2018 65M 0 0% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 65M 0 0% Jun 30, 2018 10-Q 2018-10-15
Q1 2018 65M 0 0% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 65M 0 0% Dec 31, 2017 10-K 2019-04-16
Q3 2017 65M 0 0% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 65M -1.34B -95.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 65M -1.34B -95.4% Mar 31, 2017 10-Q 2017-05-19
Q4 2016 65M 0 0% Dec 31, 2016 10-K 2018-04-17
Q3 2016 65M -1.34B -95.4% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 1.4B 0 0% Jun 30, 2016 10-Q/A 2016-08-12
Q1 2016 1.4B 0 0% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 65M -1.34B -95.4% Dec 31, 2015 10-K 2017-03-31
Q3 2015 1.4B 0 0% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 1.4B 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 1.4B 0 0% Mar 31, 2015 10-Q/A 2015-08-07
Q4 2014 1.4B 0 0% Dec 31, 2014 10-K 2016-03-29
Q3 2014 1.4B +1.2B +583% Sep 30, 2014 10-Q 2015-03-09
Q2 2014 1.4B +1.2B +583% Jun 30, 2014 10-Q 2015-08-13
Q1 2014 1.4B +1.2B +583% Mar 31, 2014 10-Q 2015-02-10
Q4 2013 1.4B +1.2B +583% Dec 31, 2013 10-K 2015-03-30
Q3 2013 205M 0 0% Sep 30, 2013 10-Q 2014-12-15
Q2 2013 205M 0 0% Jun 30, 2013 10-Q 2014-12-15
Q1 2013 205M 0 0% Mar 31, 2013 10-Q 2014-11-24
Q4 2012 205M 0 0% Dec 31, 2012 10-K 2015-01-06
Q3 2012 205M 0 0% Sep 30, 2012 10-Q 2014-07-30
Q2 2012 205M 0 0% Jun 30, 2012 10-Q 2012-08-16
Q1 2012 205M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 205M 0 0% Dec 31, 2011 10-K 2014-10-14
Q3 2011 205M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 205M Jun 30, 2011 10-Q 2011-08-18
Q4 2010 205M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.